covid -19后疲劳患者的失眠、心肺功能和生活质量

Q1 Medicine
Nathalea Spode de Arruda , Alessandra Hofstadler Deiques Fleig , Charles Rech , Carine Cristina Callegaro
{"title":"covid -19后疲劳患者的失眠、心肺功能和生活质量","authors":"Nathalea Spode de Arruda ,&nbsp;Alessandra Hofstadler Deiques Fleig ,&nbsp;Charles Rech ,&nbsp;Carine Cristina Callegaro","doi":"10.1016/j.sleepx.2024.100135","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to compare the prevalence of insomnia, lung function, inspiratory muscle function, functional capacity, and quality of life in individuals with and without post-COVID-19 fatigue.</div></div><div><h3>Methods</h3><div>Thirty-four post-COVID-19 individuals participated in the study, 20 with fatigue (32 ± 12 years old, 15% male) and 14 without fatigue (31 ± 12 years old, 42.9% male). The Chalder Fatigue Scale (CFS) was employed to categorize the volunteers into two groups: those with fatigue (score ≥4) and those without fatigue (score &lt;4). The Insomnia Severity Index (ISI) and the Epworth Sleepiness Scale (ESS) were used to assess insomnia and excessive daytime sleepiness, respectively. Pulmonary function was evaluated by spirometry, inspiratory muscle strength was assessed by the maximum inspiratory pressure (MIP), and inspiratory endurance was evaluated by maintaining an inspiratory load of 60% of MIP until fatigue. The 6-min walk test (6MWT) was used to evaluated functional capacity, while the WHOQOL-BREF questionnaire assessed quality of life.</div></div><div><h3>Results</h3><div>Individuals with post-COVID-19 fatigue demonstrated a higher prevalence of insomnia (80% vs. 49%) and excessive daytime sleepiness (45% vs. 7%), as well as lower MIP, shorter distance covered in the 6MWT, and lower FEV<sub>1</sub>/FVC (forced expired volume in the first second divided by forced vital capacity), and FEV<sub>1</sub>/FVC% of predicted. Additionally, they exhibited poorer quality of life in the physical and environmental domains. CFS demonstrated a direct correlation with ISI (r=0.436, p=0.01) and ESS (r=0.593, p=0.001), as well as an inverse correlation with the distance covered in the 6MWT (r=-0.398, p=0.022) and FEV<sub>1</sub> (r=-0.412, p=0.01). ISI was an independent predictor of CFS, with 62% of CFS variance explained by ISI variance.</div></div><div><h3>Conclusion</h3><div>Individuals with symptoms of post-COVID-19 fatigue may have a higher prevalence of insomnia, reduced inspiratory muscle strength, functional capacity, and Tiffeneau index, along with impaired quality of life. ISI is an independent predictor of post-COVID-19 fatigue.</div></div>","PeriodicalId":37065,"journal":{"name":"Sleep Medicine: X","volume":"9 ","pages":"Article 100135"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Insomnia, cardiorespiratory function and quality of life in individuals with post-COVID-19 fatigue\",\"authors\":\"Nathalea Spode de Arruda ,&nbsp;Alessandra Hofstadler Deiques Fleig ,&nbsp;Charles Rech ,&nbsp;Carine Cristina Callegaro\",\"doi\":\"10.1016/j.sleepx.2024.100135\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>This study aimed to compare the prevalence of insomnia, lung function, inspiratory muscle function, functional capacity, and quality of life in individuals with and without post-COVID-19 fatigue.</div></div><div><h3>Methods</h3><div>Thirty-four post-COVID-19 individuals participated in the study, 20 with fatigue (32 ± 12 years old, 15% male) and 14 without fatigue (31 ± 12 years old, 42.9% male). The Chalder Fatigue Scale (CFS) was employed to categorize the volunteers into two groups: those with fatigue (score ≥4) and those without fatigue (score &lt;4). The Insomnia Severity Index (ISI) and the Epworth Sleepiness Scale (ESS) were used to assess insomnia and excessive daytime sleepiness, respectively. Pulmonary function was evaluated by spirometry, inspiratory muscle strength was assessed by the maximum inspiratory pressure (MIP), and inspiratory endurance was evaluated by maintaining an inspiratory load of 60% of MIP until fatigue. The 6-min walk test (6MWT) was used to evaluated functional capacity, while the WHOQOL-BREF questionnaire assessed quality of life.</div></div><div><h3>Results</h3><div>Individuals with post-COVID-19 fatigue demonstrated a higher prevalence of insomnia (80% vs. 49%) and excessive daytime sleepiness (45% vs. 7%), as well as lower MIP, shorter distance covered in the 6MWT, and lower FEV<sub>1</sub>/FVC (forced expired volume in the first second divided by forced vital capacity), and FEV<sub>1</sub>/FVC% of predicted. Additionally, they exhibited poorer quality of life in the physical and environmental domains. CFS demonstrated a direct correlation with ISI (r=0.436, p=0.01) and ESS (r=0.593, p=0.001), as well as an inverse correlation with the distance covered in the 6MWT (r=-0.398, p=0.022) and FEV<sub>1</sub> (r=-0.412, p=0.01). ISI was an independent predictor of CFS, with 62% of CFS variance explained by ISI variance.</div></div><div><h3>Conclusion</h3><div>Individuals with symptoms of post-COVID-19 fatigue may have a higher prevalence of insomnia, reduced inspiratory muscle strength, functional capacity, and Tiffeneau index, along with impaired quality of life. ISI is an independent predictor of post-COVID-19 fatigue.</div></div>\",\"PeriodicalId\":37065,\"journal\":{\"name\":\"Sleep Medicine: X\",\"volume\":\"9 \",\"pages\":\"Article 100135\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sleep Medicine: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590142724000338\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep Medicine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590142724000338","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的比较covid -19后疲劳患者和非患者的失眠患病率、肺功能、吸气肌功能、功能容量和生活质量。方法34例新冠肺炎后患者参与研究,其中疲劳20例(年龄32±12岁,男性15%),无疲劳14例(年龄31±12岁,男性42.9%)。采用Chalder疲劳量表(CFS)将志愿者分为疲劳组(评分≥4分)和非疲劳组(评分<;4分)。失眠严重程度指数(ISI)和Epworth嗜睡量表(ESS)分别用于评估失眠和日间过度嗜睡。通过肺活量测定法评估肺功能,通过最大吸气压力(MIP)评估吸气肌力量,通过保持60% MIP的吸气负荷直到疲劳来评估吸气耐力。采用6分钟步行测试(6MWT)评估功能能力,采用WHOQOL-BREF问卷评估生活质量。结果covid -19后疲劳患者表现出更高的失眠率(80%对49%)和日间过度嗜睡(45%对7%),MIP较低,6MWT覆盖距离较短,FEV1/FVC(第一秒强制呼气体积除以强制肺活量)较低,FEV1/FVC为预测值的%。此外,他们在物理和环境领域表现出较差的生活质量。CFS与ISI (r=0.436, p=0.01)、ESS (r=0.593, p=0.001)呈正相关,与6MWT覆盖距离(r=-0.398, p=0.022)、FEV1 (r=-0.412, p=0.01)呈负相关。ISI是CFS的独立预测因子,62%的CFS方差可由ISI方差解释。结论出现新冠肺炎后疲劳症状的个体失眠发生率较高,吸气肌力量、功能能力和蒂菲诺指数下降,生活质量下降。ISI是covid -19后疲劳的独立预测因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Insomnia, cardiorespiratory function and quality of life in individuals with post-COVID-19 fatigue

Objective

This study aimed to compare the prevalence of insomnia, lung function, inspiratory muscle function, functional capacity, and quality of life in individuals with and without post-COVID-19 fatigue.

Methods

Thirty-four post-COVID-19 individuals participated in the study, 20 with fatigue (32 ± 12 years old, 15% male) and 14 without fatigue (31 ± 12 years old, 42.9% male). The Chalder Fatigue Scale (CFS) was employed to categorize the volunteers into two groups: those with fatigue (score ≥4) and those without fatigue (score <4). The Insomnia Severity Index (ISI) and the Epworth Sleepiness Scale (ESS) were used to assess insomnia and excessive daytime sleepiness, respectively. Pulmonary function was evaluated by spirometry, inspiratory muscle strength was assessed by the maximum inspiratory pressure (MIP), and inspiratory endurance was evaluated by maintaining an inspiratory load of 60% of MIP until fatigue. The 6-min walk test (6MWT) was used to evaluated functional capacity, while the WHOQOL-BREF questionnaire assessed quality of life.

Results

Individuals with post-COVID-19 fatigue demonstrated a higher prevalence of insomnia (80% vs. 49%) and excessive daytime sleepiness (45% vs. 7%), as well as lower MIP, shorter distance covered in the 6MWT, and lower FEV1/FVC (forced expired volume in the first second divided by forced vital capacity), and FEV1/FVC% of predicted. Additionally, they exhibited poorer quality of life in the physical and environmental domains. CFS demonstrated a direct correlation with ISI (r=0.436, p=0.01) and ESS (r=0.593, p=0.001), as well as an inverse correlation with the distance covered in the 6MWT (r=-0.398, p=0.022) and FEV1 (r=-0.412, p=0.01). ISI was an independent predictor of CFS, with 62% of CFS variance explained by ISI variance.

Conclusion

Individuals with symptoms of post-COVID-19 fatigue may have a higher prevalence of insomnia, reduced inspiratory muscle strength, functional capacity, and Tiffeneau index, along with impaired quality of life. ISI is an independent predictor of post-COVID-19 fatigue.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sleep Medicine: X
Sleep Medicine: X Medicine-Medicine (all)
CiteScore
4.00
自引率
0.00%
发文量
17
审稿时长
25 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信